Cardiology

Cardiology

  • João Antonio Granzotti added an answer:
    1
    In your opinion, what this flow stands for ?

    This is a left parasternal short axis view at the level of aortic valve and pulmonary artery in a 29 years full term pregnant female, she was asymptomatic, no abnormality detected on auscultation, echo was indicated before CS. 

    In your opinion, what this flow stands for ?

    João Antonio Granzotti

    The cardiac output increase during the pregnancy,and modifies the blood flow and could be appear innocent  murmur, that disappear after the childbirth

  • Abiodun Adeseye Akintunde added an answer:
    17
    Which echocardiography markers have you used to asses left ventricular diastolic function?

    left atrium volume?

    tissue doppler myocardial velocities?

    pulmonary venous flow?

    ratio  E/e LV ?

    Abiodun Adeseye Akintunde

    depending on the echocardiography machine being used. The latest technology is actually emphasizing on the use of tissue Doppler which older machines may not have. The other conventional markers such as E/A ratio, deceleration time, isovolumic relaxation time combined with pulmonary venous and hepatic systolic : diastolic flow must be combined to determine the diastolic parameters using echocardiography.

  • Tatiyana Vaikhanskaya asked a question:
    New
    ECG Challenge from https://doi.org/10.1161/CIRCULATIONAHA.116.026903

    Dr Andrés F. Miranda-Arboleda  asked a question: - "On the basis of ECG findings, what is the rhythm of the patient and what is the structural abnormality?"

    A 59-year-old man presented to our hospital reporting 3 months of exertional dyspnea, ortopnea, paroxysmal nocturnal dyspnea, and lower leg edema. On physical examination, he had jugular venous distention, bibasilar rales, large tender liver, and peripheral edema. On cardiac auscultation, he had a regular heart rate with premature ventricular contractions, systolic ejection grade III/VI cardiac murmur in pulmonic area, and louder P2 than A2. Chest x-ray showed cardiac enlargement, and an ECG (Figure 1) was recorded; ECG presented below.

     Surprising VI- V2 leads!  

    What do you think if you do not look at the link response?

  • Chalamala Srinivas added an answer:
    3
    How to write a proposal for PostDoc Fellowship?

    Recently I will be completing my Ph.D and I have started looking for Post Doc Fellowship. I need suggestions from all you guys. I have worked on Whole exome sequencing and Cardiomyopathies.

    I need a suggestions, should I stick to same research topic and further extend my Ph.D topic or switch to some other to make my proposal for Post Doc.

    Any suggestions are welcome and highly appreciated,

    Thanks

    Chalamala Srinivas
    • http://imperialandglobal.exeter.ac.uk/2014/02/a-beginners-guide-to-writing-a-post-doc-research-proposal/

    + 2 more attachments

  • Paul Grossman added an answer:
    14
    After 20 years of "polyvagal" hypotheses, is there any direct evidence for the first 3 premises that form the foundation of the polyvagal conjectures?

    Premise 1: Neurogenic bradycardia and RSA are mediated by different branches of the vagus and need not respond in concert.

    Premise 2: Neurogenic bradycardia associated with orienting is a phylogenetic vestigial relic of the reptilian brain and is mediated by the dorsal motor nucleus (DMNX).

    Premise 3: Withdrawal of cardiac vagal tone through Nucleus Ambiguus (NA) mechanisms is a mammalian adaptation to select novelty in the environment while coping with the need to maintain metabolic output and continuous social communication.
    (From Porges SW (2013) Polvagal Theory. NY: Norton)

    The current evolutionary vagal evidence indicates that neither Premises 2 nor 3 are accurate. Also 1) there is a confluence of evidence regarding Premise 1 showing that the DMNX  may only manifest vagal effects upon heart rate under conditions of severe physiological respiratory distress (and even this is not very well documented), 2) Porges provides  merely very indirect findings to support his hypothesis (and his Figure 2.3 of  the time course of putative DMNX-stimulated bradycardia in a single anesthetized rabbit shows much too rapid onset and offset for the heart rate drop to be a response of the unmyelinated DMNX vagal fibers [which should have a much more gradual onset and offset than shown because slow conduction time of these fibers prevent sudden changes]), and 3) no mention is made by Porges of earlier findings that indicate that the DMNX is not implicated in normal vagal control of heart rate.

    Nevertheless, perhaps there are strands of direct evidence of which I am unaware? In any case, polvagal conjectures have become very popular in psychology, psychophysiology and therapy literature. It seems, therefore, high time to critically assess the value of Stephen Porges' ideas in this area.

    Paul Grossman

    Also added to the project, https://www.researchgate.net/project/Examining-Porges-Polyvagal-suppositions

    Still no evidence for the polyvagal speculations and only very substantial evidence against
     
    In this time of "fake news," "alternative facts," "post-truth modernism," "creating one's own reality" (Karl Rove from Suskind, NY Times 2004) and surviving 2017 in Trumplandia, it seems more important than ever to question controversial ideas in "Science" that parade as fact and can have significant impact upon people's lives and pocket books, as well as upon future research directions. Although I have opened up discussion about polyvagal notions a year and a half ago, although probably more than 5000 researchers have viewed the above-mentioned project and/or this question, there has not been a single strand of evidence offered in support of things polyvagal and my colleagues in evolutionary biology and cardiovascular autonomic physiology completely discount the polyvagal suppositions. Evolution of the autonomic nervous system does not seems to work the way the polyvagal assertions claim, nor does the brainstem dorsal motor nucleus appear to play any significant role in regulation of parasympathetic influences upon heart rate. Each of these points is very well substantiated, and each provides--by itself--a source of refutation of the polyvagal speculations. On the other hand, I have personally been at lectures of Steven Porges (the author of things polyvagal) in which he claims the opposite, as though his contentions were fact.
     
    Ten years ago, a very prominent expert on the evolution of the autonomic nervous system (Edwin [Ted] Taylor) and I published a multi-tiered refutation of the polyvagal ideas (attached). Cited almost 600 times (Google Scholar), with not one serious critique of our arguments, its publication has done nothing to stem the tide of enthusiasm for polyvagal suppositions. Two years ago, Ted Taylor asked what can we further do to bring some science into this area: my ResearchGate attempts at dialogue result from his and another well known autonomic evolutionary biologist 's (Tobias Wang) frustration with this business. They wanted to write another paper. However, I thought this ResearchGate avenue might actually reach more researchers--young and old—as well as provide a platform for serious discussion, pro and contra, unhampered by biases of conventional journal publications. I figured that if I could support my ideas with accessible literature documentation (see link above), we could have a lively debate about things.


    6000 reads later, only several additionally critical comments about the polyvagal (and most of them in private mails to me), but no dialogue: So what is going on in our "science" and "research"? Has our discipline succumbed to the same sociopolitical and economic forces as the rest of our Western institutions? Are proponents of polyvagal ideas merely keeping quiet in the hope that critical discussion may simply fade away? Are they wary of an open discussion? Are they or the opposite school afraid that funding possibilities may be diminished, should they enter the dialogue? Do researchers feel so profoundly insecure in their knowledge of the issues involved that they fear for entering a discussion? Or has this area of polyvagalness become a place where believers can merely exercise their beliefs and provide a plausible (if untrue) metaphor for relations between mind and body? Or maybe there are other reasons for this state of affairs (please tell)?


    Anyhow, I continue to find this a fascinating and curious situation, and I will persist to try to stimulate discussion. We will see what happens.

  • Sergey Kozhukhov added an answer:
    8
    Markers of early fibrosis in heart tissue

    I am trying to measure markers of early fibrosis in heart tissue of spontaneously hypertensive heart failure rats. Echocardiographic data shows that my drug treatment improved diastolic dysfunction, while untreated animal group had a prolonged IVRT (a marker of diastolic dysfunction).

    Since one possible contributor to diastolic dysfunction is fibrosis, I will like to probe for markers of fibrosis (preferably early fibrosis) in the treated versus untreated animal groups. I am thinking in the line of Collagen I or III and fibronectin?? Does anyone has other ideas of what could be a great marker of fibrosis or diastolic dysfunction? 

    Are there other factors that could contribute to diastolic function that I can probe at the molecular levels?? 

    Meanwhile the animals still had normal ejection fraction so they are not yet in the decompensated heart failure stage.

    Thank you.

    B.

    Sergey Kozhukhov

    Additional information maybe helpful.

    Please see ANMCO/ELAS/SIBioC Consensus Document published in May 2017.

    Point 1. There are still some doubts on efficiency, prognostic role, and cost-effectiveness of biomarkers of cardiac remodelling and myocardial fibrosis, even if many studies have been published recently.

    Point 2. Considering the wide range of biomarkers of cardiac remodelling and myocardial fibrosis, the clinician should direct his decision remembering the analytical characteristics of the assay, the efficiency and prognostic effectiveness of the biomarker also in relation to patients’ setting, possible confounding variables, co-morbidities and costs.

    Point 3. Novel biomarkers and multi-markers models

    The search is still open for novel biomarkers useful for prognosis and guide therapy in HF patients. Promising candidate biomarker may be: growth differential factor-15 (GDF-15), carbohydrate antigen-125 (CA-125), C-terminal pro-vasopressin (copectin), mid-regional pro-adrenomedullin (MR-proADM), NEP and orexin. Some of these molecules have been utilized for many years as tumour-markers (CA-125), neuro-hormones (copeptin, MR-proADM) or inflammatory markers (GDF-15) in clinical practice.

  • Vincent L Mendy added an answer:
    12
    Can anyone suggest a validated questionnaire to assess awareness of cardiovascular risk?
    I am currently exploring the prevalence and awareness of cardiovascular risk factors among bankers.
    Vincent L Mendy

    Here is a link to the Delta CHES,

    http://msdh.ms.gov/msdhsite/_static/44,0,353.html

    assessing CVD risk in the Mississippi Delta region

  • Adriano Carnevali added an answer:
    2
    Does any one know where can be found list of journal Impact Factor 2016?

    Cardiology field

    Adriano Carnevali

    https://login.webofknowledge.com/error/Error?Src=IP&Alias=WOK5&Error=IPError&Params=&PathInfo=%2F&RouterURL=https%3A%2F%2Fwww.webofknowledge.com%2F&Domain=.webofknowledge.com

  • Rio Jorge Aguilar added an answer:
    3
    Is there is any change of pulmonary venous pressure during systole and diastole of cardiac cycle?

    Pulmonary vein, pressure change, systole, diastole,, disease.. And normal heart.. 

    Rio Jorge Aguilar

    PV pressure as it has been said above reflects changes in LA pressure (if do you want I have added a book chapter related with this topic, you can see LA pressure changes during cardiac cycle in table 1 and figure 1)  and its interaction with pulmonary venous capacitance-resistance and also importantly changes in Intrathoracic pressures.

  • Anup Kumar Bandyopadhyay added an answer:
    2
    Is there any danger to take Eplerenone for a long time?

    Eplerenone is used in cardiac problem. Is there any danger to use this medicine for a prolonged period?

    Anup Kumar Bandyopadhyay

    Thank you very much for your answer.

    Regards,

    Anup

  • Eugenio Picano added an answer:
    5
    Dear colleagues, is there any Russian clinics participating in project?

    I'm cardiologist in CCU and I'm very interested in performing stress-echo in valvular patients. I hope, it would be very useful for patients to be redirected to hospitals participating in the project. 

    Eugenio Picano

    Cardiology Department,  Medika Cardiocenter, Saint Petersburg, Russian Federation

  • Asad Muyinda added an answer:
    3
    What is CT FFR? What is the role of combined CT FFR and CT coronary angiography in diagnosis of ischaemic heart disease?

    Can in future combined CT FFR and CT coronary angiography replace invasive coronary angiography for diagnosis of CAD ?

    Asad Muyinda

    Fractional Flow Reserve-FFR ; Fraction of hymodynamic in Stenosed Vessel: Normal Vessel. FFR of 70% reflects a 30% drop in Hemodynamics.

    Computed tomography-derived FFR[CT-FFR]

    Employs ; Modeling of coronary arteries &  blood flow

    Prior Technology had Poor Correlation With Invasive Coronary Angiography[ICA] but Using 3D FFRCT +Heart Flow FFR-CT SoftWare, Results are PRETTY KOOL.

    The results showed that Heart Flow FFR-CT was able to correctly identify 84 % of the significant blockages identified by FFR as requiring intervention, and 86 % of blockages identified by FFR as not requiring intervention.

    Each method has its Pros & Cons, but with latest advances in Hemodynamic Software, CT-FFR will replace ICA.

    https://www.dicardiology.com/product/fda-clears-ffr-ct

  • Johannes Neumeister added an answer:
    2
    Dear colleagues, what are your experiences of an assocation of pulmonary haemorrhage and the LUCAS compression device for CPR?

    I have recently repeatedly observed pulmonary haemorrhage in association to an appropriate use of the LUCAS device by different team for OHCA CPR. This was very different from haemorrhagic secretions, that can somtimes occur during prolonged CPR.

    Any thoughts or experience?

    Thanks

    Tobias

    Johannes Neumeister

    Dear Tobias,

    We use LUCAS on a regular basis- in and out Hospital - but do not see that often.

    In those cases with bleeding complications - Lysis after fulminat PE , renal insufficiency, OAK or therapeutic dosage of heparin  etc. were involved...

    I also think that bleeding complications are dependent on your patients characteristics.

    Greez

  • Washington Ricardo Macias Cornejo asked a question:
    Open
    I would like to ResearchGate's about recruiting to take doctorate course (PhD) in cardiology and related

    I would like to ResearchGate's about recruiting to take doctorate course (PhD) in cardiology and related areafor Latin Americans in universities or institucuiones with spanish or portuguese language

  • Asad Muyinda added an answer:
    4
    Is this WPW, LBBB or both?

    A 36 year old man with recurrent palpitations.

    Asad Muyinda

    GREAT Case

    EKG INTERPRETATION

    LBBB +LAEnlargement

    PRWProgressionn NOTED, possibility of Ischemia as cause of LBBB

    DELTA WAVES[More Marked in aVL] + Short PR intervals noted.==>WPW[Type B]

  • Victoria Barbara added an answer:
    3
    What is the highest troponin achieved post myocardian ischaemia?

    what is the highest troponin achieved post myocardian ischaemia?

    Victoria Barbara

    I have a troponin I  on my wall right now from april 2009 that reach 1593.5

  • Tatiyana Vaikhanskaya added an answer:
    5
    What ment Linzbach in the 50ies of the last century when talking about " Gefügedilatation"?

    A late event In Constrictive ventricular hypertrophy is a sudden dilatation, which clinicians understand to be a critical sign of impending final heart failure. Linzbach, the famous german Cardiopathologist, introduced into literature the term " Gefügedilatation" hence suggesting that the myocardial alignmrent is rearranged such that the heart dilates. Unfortunately, even his pupil famousWaldemar Hort could explain after Linzbach died, how his teacher had conceived  the reallignment might happen.

    Tatiyana Vaikhanskaya

    Dear Dr. Paul Peter Lunkenheimer. It was interesting to learn about the original hypotheses of your compatriot as well as the morphofunctional model that is remarkably presented in your article "Models of Ventricular Structure and Function Reviewed for Clinical Cardiologists". Thanks

  • Philomina Joseph added an answer:
    17
    What is the rhythm in this ECG of a 65 year old with heart failure?s the rhythm in this ECG of a 65 year old with heart failure?

    A long standing hypertensive patient with heart failure of reduced ejection fraction. He is in functional class II and recently presented with bradycardia increasing fatigue.

    Philomina Joseph

    2:1 HB

  • Basil Okeahialam added an answer:
    6
    Is there is any role of nevibolol in the management of heart failure with preserved ejjection fraction?

    Heart, failure, diastolic, nevibolol 

    Basil Okeahialam

    My answer is yes. Nebivolol is a modern cardio selective beta 3 blocker. When the heart fails with preservation of systolic function, drugs in this class reduce tachycardia which adversely impacts diastolic function and by reducing tachycardia improve myocardial perfusion. It also causes myocardial hypertrophic regression which improves diastolic compliance and function. By its mechanism of function it is not adverse to systolic function while at the same time improves diastolic function

  • Deborah Darlene Williams added an answer:
    3
    AAA size matters: When is Pharm Nuclear Testing (Cardiac PET/SPECT with Lexiscan) preferred over Dobutamine Stress Echo for pre-op evaluation?

    At what AAA size would you consider Cardiac Nuclear PET/SPECT with Lexiscan over Dobutamine Stress Echo? (outpatient setting)

    How important is the potential for a hypertensive blood pressure response with use of Dobutamine?

    How important is the presence or absence of a previously placed graft?

    What are other clinical factors on which you would base your decision?

    -comments greatly appreciated!

    Deborah Williams, NP 

    Deborah Darlene Williams

    Thank you Dr. Majumder,

    I'm inclined to agree. Consideration should be given to alternative cardiac evaluation options, unless otherwise contraindicated.  

    Quite a few factors to consider--including AAA sizes > 6 cm and blood pressure.  I've seen blood pressure responses to Dobutamine range between 60 mmHg and as high as 200 mmHg. For some patients, beta blockers are held prior to Dobutamine stress echo. It is not always easy to predict BP responses.  

  • Andrea Pozzati added an answer:
    12
    Should cardiac CT angiography be incorporated as part of acute chest pain evaluation?

    Cardiac CT angiography, aortic dissection, pulmonary embolism, acute chest pain

    Andrea Pozzati

    yes in patients with severe pain, because you can exclude triple etiology: coronary, aortic or pulmonary embolic chest pain

  • Abhilash Koratala added an answer:
    3
    Wheather adding statin will be beneficial in low risk cardiovascular patient groups? Is there is any data or research papper?

    statin use,low risk cardiovascular patient,mortality benifit,

    Abhilash Koratala

    CMAJ. 2011 Nov 8; 183(16): 1821–1823.
    doi:  10.1503/cmaj.111674

    This commentary is helpful. This comments on the above article mentioned by Dr. Pesl as well.

  • Tatiyana Vaikhanskaya added an answer:
    1
    Can modern gadgets replace stethoscope in current cardiology practice?

    Cardiology, stethoscope, modern era

    Tatiyana Vaikhanskaya

    That’s the idea behind the Eko Core, a tool that brings the modern stethoscope into the age of the smartphone and cloud computing.

    The Core, developed by Berkeley, California-based startup Eko Devices, pairs with a smartphone or tablet over Bluetooth, and records heart sounds. The audio can instantly be shared with a cardiologist anywhere for an expert opinion, or compared to heart sounds in a cloud-based database, to help discern the likelihood of a heart murmur or other serious issue. 

    A few stethoscopes already on the market have the ability to record. 3M’s Littmann 3200, for instance, can record and store up to 12 heart readings. But it pairs with a proprietary USB dongle, so is meant to be used with a desktop or laptop computer, not mobile devices, and Apple products are not supported.


    Read more: http://www.smithsonianmag.com/innovation/smart-stethoscope-attachment-could-lead-more-accurate-diagnoses-180953912/#5ITc31IkwdupWDAZ.99

  • Tatiyana Vaikhanskaya added an answer:
    4
    How to suspect possibility of reversible cause of dilated cardiography from echocardiography?

    How to suspect reversible cause of dilated cardiomyopathy from echocardiography? 

    Tatiyana Vaikhanskaya

    Obesity, tachycardia, and extreme stress have all been shown to result in impaired left ventricular function and dilatation. Several of these reversible CMs, including:

    • Tachycardia-induced (ECG and ECHO: arrhythmias include atrial fibrillation, atrial flutter, atrial tachycardia, reentrant supraventricular tachycardia, accessory pathway tachycardia, frequent ectopic beats, and ventricular tachycardia. Persistent tachycardia causes elevated ventricular filling pressures, severe biventricular systolic dysfunction, reduced cardiac output, and elevated systemic vascular resistance)
    • Takotsubo (contractile function of the mid and apical segments of the LV are depressed and there is hyperkinesis of the basal walls, producing a balloon-like appearance of the distal ventricle with systole)
    • Sepsis-induced cardiomyopathy (Increased LVEDP is indicative of diastolic dysfunction in sepsis patients),
    • Thyroid Disease–Induced Cardiomyopathy (systemic changes in cardiac function due to reduced peripheral vascular resistance, activation of the renin–angiotensin mechanism, increased LV end-diastolic volume (LVEDV) and increased preload; the increased preload and decreased peripheral vascular resistance leads to a high cardiac output, even at rest, resulting in CM. In contrast to hyperthyroidism, hypothyroidism causes a low cardiac output CM via the same pathways mentioned above, however, by downregulating the previously mentioned receptors/channels causing decreased myocardial excitation and contractility leading to a low-output CM)
    • Peripartum CM (by clinical criteria: ( development of heart failure symptoms either during the last month of pregnancy or within the first 5 months after delivery;  no other identifiable causes of HF exist; no evidence of heart disease prior to the last month of pregnancy)
    • Inflammatory CM (there are both non-infectious and infectious causes . Non- infectious origins include toxins, alcohol, cytotoxic chemotherapy, and metabolic abnormalities)
  • Biswajit Majumder added an answer:
    5
    Why do we feel the need to evaluate the factors causing decline of ECG use?

    Echo helps in seeing the chambers and  valves at the same time. It seems to be a better option for diagnosing congenital heart diseases. What benefits of ECG have led to this research? 

    Biswajit Majumder

    Echo is useful for diagnosing structural heart disease. Echodoppler also gives indirect and direct haemodynamic parameter of critically unwell newborn which has got therapeutic relevance. Ecg is useful for diagnosing arrhythmia. However Ecg finding may be adjuncting with echo finding to diagnose certain disease like Pompe's disease. Ecg maybe also helpful for followup of children with family history of certain genetic disease like Damon disease, HCM where Ecg is abnormal but echo may be normal. 

  • Eldad Rechavia added an answer:
    12
    What is the rhythm in this EKG?

    A 52 year old man with DCM, came to the ER with palpitations and worsening  dyspnoea.

    Eldad Rechavia

    Atrial Tachycardia

  • Michail Spartalis added an answer:
    3
    Can anyone recommend a database of Echocardiographic images?

    I want to do a project on abnormal echocardiogram using MATLAB, but i can't find any Open Access database.

    any suggestions

    Michail Spartalis

    www.echobasics.de

    https://www.escardio.org/Education/Practice-Tools/EACVI-toolboxes/3D-Echo/Clinical-cases

  • Christoph Kampmann added an answer:
    3
    What cardiomyopathy needs to be differentiated in children under dynamic follow-up? What potential genes should be examined?

    A mini-case report. History-evolution of the family disease from peripartal CMP to cardiac transplantation:

     - Disease manifested in 35-year-old female to the last trimester of the pregnancy as peripartal cardiomyopathy.  Heredity is burdened by the SCD of her mother at the 29-year age.

    - ECG 2015: a high voltage complex, WPW phenomenon. ECHO:  LV EDVol 187 ml;  LV ESVol 135 ml;   LVEF  28%; GLS  -10.4%;

     After 12-18 months post delivery the condition worsened. There were signs of progressive heart failure with  biventricular dilatation and systolic dysfunction.

    - ECHO 2017: LV EDVol 290 ml;  LV ESVol 242 ml;   LVEF  17%; GLS  -5.1%;RV EDVol 64 ml;  RV ESVol  43 ml;  RVEF 32%;  GLS  -9.8%; TPSE 12 mm; index of myocardial mass is 135 g / m2,  RV free wall thickness  8 mm, LV free wall thickness 9 mm.

     - ECG 2017 :  Atrial Flutter, atypical LBBB pattern with "pseudo-infarction" signs of Sodi-Polares (QS in I, avL, V5-V6) and Cabrera (V4).

    N-terminal proBNP 16766 pg / mmol.

    Cardiac MRI revealed  signs of subendocardial linear fibrosis (areas of poor gadolinium uptake that indicate scarring).

    ECG and MRI results are in the attached file (mother)

    A successful heart transplant (HTx) was performed in the patient.

    Since our patient has three children - sons 16,10 and 2 years old, we examined them: Еcho normal, ECG abnormal (see the file attached below).

    What cardiomyopathy needs to be differentiated in children under dynamic follow-up? What potential genes should be examined?

    + 1 more attachment

    Christoph Kampmann

    i share the same opinion than Joseph an Biswajit, about Danon Disease. which is x-linked. the WPW shape is not realy a WPW because the PR interval is not abbreviated.

    best

  • Daniel Teodoru added an answer:
    27
    Is Left Ventricular Ejection Fraction (LVEF) reliable as measured by an echo?
    I have a 50 year old patient who had an inferior wall MI 2 and a half years back and is on Aspirin, Clopidogrel and Statins. He does not have hypertension or diabetes. A year after the MI, his cardiologist reported his LVEF to be 55-60% after an echo. A year and a half later, a repeat echo was performed (for routine purposes), and the cardiologist reported 50-55% LVEF and Grade 1 diastolic dysfunction. The patient is currently asymptomatic and is here for regular follow up. However he is a smoker but smokes only 1-2 cigarettes per day - he is on a plan to quit smoking gradually. I was wondering whether the decrease in LVEF is worrisome? Is LVEF a reliable measurement? Is it true that it undergoes day to day variations? Any help would be appreciated! Thanks!
    Daniel Teodoru

    I wonder how much more reliable is stressed nucleotide study and how has global longitudinal stress speckles study improved long term predictive power. The latter, I believe, is a matter of software.

  • Gerhard Rakhorst added an answer:
    2
    I could use advice on using urethane to anesthetize pigs (swine)?

    I am planning a study using an anesthetized pig model to better understand bladder filling and motion. From the literature, it seems that urethane would be the best anesthetic for the study, because it does not change the bladder motion or bladder capacity as much as other anesthetics. In the literature, I've seen many different administration methods used, so would you recommend a slow, IV drip or a large bolus at the start of the study? If we do the large bolus (~1.2 g/kg seems common), who long does it last in a pig?

    Gerhard Rakhorst

    I am not familiar with urethane as an anesthetic agent. I would recomment ketamine intramuscular with Vetranquil and Fluothane as inhalent.

  • Biswajit Majumder added an answer:
    5
    Does any one have information about detection of endothelial dysfunction in umbilical artery?

    Acetylcholine lacks relaxatory effect in this artery

    Biswajit Majumder

    Hi, Rezhna      Endothelial dysfunction in umbilical artery may be an important  predictor of future atherosclerosis. Expression  of NO synthases(eNOS,iNOS,nNOS).pro oxidative enzymes and antioxidative enzymes like supernatural dismutase1-3,glutathione peroxidase1in umbilical arteries may be helpful in detecting Endothelial dysfunction. It has clinical implication. Small and large for gestesional age babies have Endothelial dysfunction in umbilical artery compared to appropriate for gestesional age babies and they are having higher risk of future  development of atherosclerosis. 

  • Ghid Kanaan added an answer:
    10
    What an ECG abnormalities are present?

    14-year-old girl  presented with permanent neurological
    disorder impairing motor skills, comprehension,
    and memory. She began to have an epileptiform seizures.
    ECG is shown in Figure below

    Ghid Kanaan

    Dear Dr. Tatiyana,

     Really, it is beyond any word that can express my sincere gratitude and deep appreciation to you.

    Actually, the first and foremost thanks are owed to you, for opening such a valuable wonderful discussion about such an interesting case, engaging colleagues from different scientific backgrounds and it will always be greatly appreciated to you Dr. Tatiyana for keeping us updated in regard to any result.

    Indeed, it gives me great pleasure to express my heartfelt thanks and utmost respect to you Dr. Tatiyana.

    Respectfully yours.

  • Anatoly Zhirkov added an answer:
    6
    What is the ideal constant pressure (not range) after you mount a mesenteric vessel in between 2 cannulas?

    Some papers suggest low as 60mmHg, some suggest as high as 80mmHg

    Anatoly Zhirkov

    If you agree that "optimal BP" need for optimal blood flow

  • Mayela Labarca added an answer:
    52
    Young Investigators Research in Cardiology, Electrophysiolohy - Are you interested in collaboration?

    I was just wondering if young investigators from Europe and the US would be interested in collaborating on multicenter clinical trials in the field of cardiology and electrophysiology. This may help those at the beginning of their career establishing them as potent partners in clinical cardiology research.

    Looking forward to hearing your thoughts.

    Mayela Labarca

    Good Morning, my name is Mayela Labarca, I'm an internal Medicine specialist and a non invasive clinical research cardiologist with a  3 years research Master in  Cardiovascular Diseases and 1 additional year training in electrophysiology, I'm looking forward to join the research group

  • Vladislavs Sokalskis added an answer:
    12
    Anyone worked with Global Longitudinal Strain in pre and post TAVI ?!
    Searching for a related topic to pursue research on.
    Vladislavs Sokalskis

    Here is a link showing an advantage of using strain during post-TAVI evaluation of the patient. Basically, LV GLS shall improve >1.5% to be sure that the patient has a good prognosis.

    bit.ly/2j5wpmM

  • Vladislavs Sokalskis added an answer:
    4
    Any advice on the management of the asymptomatic aorta valve stenosis (Accent on the preoperative time)?

    How manage preoperative time of  the patients with asymptomatic significant aorta stenosis? Should patient wait for the surgery at home or at the hospital? What criteria for select (home, hospital)? The risk stratification of the sudden cardiac death of the asymptomatic AS patient? And what is your own opinion, practice of the management of the preoperative time?

    Thank you!

    Vladislavs Sokalskis

    I guess it depends indeed more on symptoms, on functional capacity of a patient and maybe on NT-proBNP levels than specific echocardiographic findings. But Sir you are right, at the moment it is still a very subjective decision. 

  • Jesús Salvador Valencia-Sánchez asked a question:
    Open
    When does the project begin?

    I am really interested in participating in the proyect. For a long time I worked in the urgency department of the Cardiology Hospital IMSS.

    Best Regards,

    Jesus Valencia MD

  • Mohammed M Hassan asked a question:
    Open
    Why do we use the dual injection in nuclear cardio scanning?

    why do the patients take two different doses for nuclear cardio scanning (rest + stress), is there any difference in the mechanism of the behavior of the tc99m with mitochondria in the two doses

  • Mayela Labarca added an answer:
    3
    I would be happy to participate. How can I be a member of the group?

    I'm a cardiologist

    Mayela Labarca

     Good morning, I'm Mayela Labarca, an internist with 3 years training as a  Máster in research in Cardiovascular Diseases, currently working as a clinical research cardiologist in Maracaibo,, Venezuela, I'm interested in joining the  Cardiovascular Meta-analyses Research Group, could that be possible? 

  • Francesca Vanni added an answer:
    2
    Suturability test protocol for cardiac patch?

    Hello,

    I'm looking for suturability test protocol for cardiac patch ( possibly according to ISO norm).

    Thank you very much,

    Francesca.

    Francesca Vanni

    Thank you so much Deon!!!

  • Kamal Heer added an answer:
    5
    Does anybody know about pneumoperitoneum that develops after the colonic stent implantation in patients with severe malignant colonic stenosis?

    Within the last few years, I experienced three cases of pneumoperitoneum with and without pneumomediastinum developed immediately after the colonic stent implantation in patients with severe malignant colonic stenosis. Despite the presence of pneumoperitoneum, no patients complained about abdominal pain and presented peritoneal irritation. Moreover, there was no evidence of panperitonitis and elevated inflammatory reactions. Oral intake became possible after the deployment of colonic stents. All these patients underwent surgical resection of colon cancers. Operative findings revealed no evidence of colonic perforation. Postoperative course was uneventful. Does anybody have concerns about pneumoperitoneum that develops after the colonic stent implantation in patients with severe malignant colonic stenosis?

    Kamal Heer

    I must say, I agree with Dr Wong. Close monitoring is indicated, but, even if the incidence of an asymptomatic pneumoperitoneum were 10%, I would find routine post-procedure CT difficult to justify, considering management is based on the clinical findings. The scenario in oesophageal stenting is much different, where spontaneous resolution is not the norm and one has to look for pneumomediastinum proactively. 

  • Barbara Nuñez Fernandez asked a question:
    Open
    "Personalised External Aortic Root Support (PEARS)" as an alternative to David Procedure for Aneurysms of the Aortic Root and Ascending Aorta?

    I would like to know your opinions about "Personalised External Aortic Root Support (PEARS)" as an alternative to David Procedure.

    http://www.exstent.com/images/contentpage/downloads/Treasure%20Petrou%20et%20al%20PEARS%202016.pdf

    http://heart.bmj.com/content/early/2014/01/06/heartjnl-2013-304913.full.pdf+html

    http://www.marfanaorticrootsupport.org/images/downloads/Hamilton%20PEARS%202016.pdf

  • Steven B Karch added an answer:
    12
    During and after commotio cordis can the victim still move around?

    Thanks for your kind response.  I attach a file elaborating on my particular deliberation?

  • Peter J Little added an answer:
    2
    We have done some experiments with the peptide G alpha q inhibitor known as GP-2A - the results are very erratic - anybody else tried?

    Some days it inhibits a G alpha q response and some days not - also very fresh never thawed stock does not appear to be the answer. 

    There are not many publications and this might be why.

    On one occasion it gave a beautiful full and fairly potent dose response curve and it did not inhibit at all on another day - same expt - is very hard to understand. 

    Peter J Little

    Many publications? - I think we can find 3 or 4.

  • Jesus Prieto-Lloret added an answer:
    4
    How to analyse blood pressure differences during before the exercise and after the exercise? Can we use delta (Post-Pre) change?

    We are working on blood pressure responses during steady treadmill exercise. Rise in blood pressure occurs during the exercise. So can we use this difference as a Delta or not?

    Jesus Prieto-Lloret

    It is perfectly normal to calculate the delta, as in figures 1C and 1F (representing responses in pulmonary arterial pressure) in the paper below.

    Expressing the data in this way can give a better idea of the responses from pre  to post exercise situation. Maybe it is already your intention: why not taking different time points during/after the exercise? You could get pressure values every minute for example, to study its evolution during exercise, and the recovery pattern afterwards. It would give you a kinetic graph with delta values over time.

    • Source
      [Show abstract] [Hide abstract] ABSTRACT: Adult mammalians possess three cell systems that are activated by acute bodily hypoxia: pulmonary artery smooth muscle cells (PASMC), carotid body chemoreceptor cells (CBCC) and erythropoietin (EPO)-producing cells. In rats, chronic perinatal hyperoxia causes permanent carotid body (CB) atrophy and functional alterations of surviving CBCC. There are no studies on PASMC or EPO-producing cells. Our aim has been to define possible long-lasting functional changes in PASMC or EPO-producing cells (measured as EPO plasma levels), and further analyzing CBCC functional alterations. We have used 3-4 month old rats born and reared in normal atmosphere or exposed to perinatal hyperoxia (55-60% O2 for the last 5-6 days of pregnancy and 4 weeks after birth). Perinatal hyperoxia causes a nearly complete loss of hypoxic pulmonary vasoconstriction (HPV) which was correlated with lung oxidative status in early postnatal life and prevented by antioxidant supplementation in the diet. O2 -sensitivity of K(+) currents in PASMC of hyperoxic animals are normal indicating that their inhibition is not sufficient for triggering HPV. Perinatal hyperoxia also abrogated responses elicited by hypoxia on catecholamine and cAMP metabolism in the CB. Increase in EPO plasma levels elicited by hypoxia was identical in hyperoxic and control animals, implying a normal functioning of EPO producing cells. The loss of HPV observed in adult rats and caused by perinatal hyperoxia, comparable to oxygen therapy in premature infants, might represent a not previously recognized complication of such a medical intervention capable of aggravating medical conditions like regional pneumonias, atelectases or general anaesthesia in adult life. This article is protected by copyright. All rights reserved. This article is protected by copyright. All rights reserved.
      Full-text available · Article · Apr 2015 · The Journal of Physiology
  • Mark Ian Munro Noble added an answer:
    11
    Troponin and other cardiac injury marker elevated after prolonged exercise, is it pathological or physiological?

    There are evidence troponin and other cardiac injury marker such as CK-MB, NT Pro BNP, etc elevated after prolonged endurance exercise. Some studies show that it happens 30% or even almost 90% of participants in marathon, ultha marathon, long distance cycling, thriathlon and other kind of sports. According to your knowledge and your experiences is it pathological or physiological process?

    Mark Ian Munro Noble

    If the subject is a fully trained stamina athlete such as a long distance runner, he/she may have cardiac hypertrophy that I regard as a pathological condition, but my colleagues above may consider physiological!

  • Halszka Bąk added an answer:
    5
    Real-life normal human heartbeat sounds - resources?

    I am looking for real-life high definition recordings of human heartbeat both fast (100-120BPM) and normal/slow (60BPM). I am aware that there is a happy abundance of royalty-free synthetic sounds and sound effects created to imitate heartbeat, and I am not interested in those. I am looking specifically for real-life recordings. Something that could be used to train cardiologists, say. 

    No need for those recordings to be long, something like 10 seconds would be enough, but longer recordings would be prefereable. Both mono and stereo tracks are fine.

    I appreciate any and all help, and I will, of course credit appropriatelyany sources proposed if I use them.

    Halszka Bąk

    Thanks everyone! All of these are much better than anything I could find on my own. RG community is the best! 

  • Tatiyana Vaikhanskaya added an answer:
    18
    What diagnostic algorithm should be performed for patients with these ECG changes?

    The first complaint of the patient (54 years, male) appeared  as presyncope and palpitations. A year earlier he developed AF paroxysm and was treated by metoprololi; at that time coronary angiography was performed and found that that his arteries were without changes. Presently, as a result by Echo no structural abnormality of the heart was revealed: LVEF 66%, LVEDV-124 ml, LVEDD-51 mm, the right heart chamber are not expanded, RV EF - 57%. However, by HM-ECG were revealed episodes of ST-elevation at night time (prolonged and brady-dependent) and ventricular arrythmyas. HM-ECG strip attached below. What is the next step of diagnosis is required?

    Tatiyana Vaikhanskaya

    Yes, I suppose that is so

  • Aurelio Chaux added an answer:
    4
    Is it feasible to treat organic tricuspid valve disease in patient with well-functioning mitral valve prosthesis?

    I met many patients who had undergone mitral valve replacement for rheumatic mitral valve diseased and the surgeons had missed the organic tricuspid valve disease and leave it without repair and the net result after some time is a patient with well-functioning mitral valve prosthesis and organic tricuspid valve disease  with severe tricuspid stenosis and/or regurgitation with marked systemic congestion, ascitis, and sometimes even cardiac liver cirrhosis. The question is about the cardiac surgery for just repair of tricuspid valve in such cases, is it feasible ?

    Aurelio Chaux

    I agree with the fact that it is possible to surgically intervene if medical treatment is not controlling the situation. To me the must important point is that patients should be properly diagnosed and thoroughly evaluated prior to the initial surgery and surgeons should have the knowledge, criterion, training and expertise, to perform the correct and complete surgical procedure during the initial operation.

  • Siddharth Sarangi added an answer:
    6
    A male patient, 60 years, came with infero-posterior MI and received streptokinase and this is his echocardiogram at day 6. What could it be?

    This echocariogram was obtained at day 6 after acute infero-posterior STEMI of a 60 years old man in a peripheral hospital with no primary PCI capability. He was hemodynamically stable, without chest pain and was lying flat in bed. Echocardiography was done before discharge to prepare him for angiography. What is the appropriate management in such case ?

    Siddharth Sarangi

    Awesome job Mohammad. Keep it up.

  • Ijeoma Arodiwe added an answer:
    8
    The pulse may vary in volume between the two arms e.g in case of aortic dissection, but is there any cause for pulse variation in its rate?

    Cardiology, Physiology, Internal Medicine

    Ijeoma Arodiwe

    The flap can extend into the its first branch leading to obstruction and non  conduction of  a beat

  • Leonid Makarov added an answer:
    2
    Who have pts with AVB 2 and a R214Q variant in exon 3A of SCN1Bb?

    Dear collegues I have two twins 8 yo with AB block 1-2 (type 1), wihout syncope in history (both active young athletes). Molecular Gene analyse a R214Q variant were detected in exon 3A of SCN1Bb in both brothers and his mother (without AVB and syncope). What your mention about prognosis, PCM implantation and follow up.

    Sincerely yours

    Dr.Leonid Makarov Ph.D.     

    Leonid Makarov

    Dear dr. Kamhman, thank you very much for your mention. Really in papers Holst (Can J Cardiol 2012) , Olesen M (Heart Rhythm 2012) were described this mutation in adult pta with BrS, AF. But in observation of the Hu D. (Heart Rhythm 2012) was  revealed one child 4 month who died from SIDS with the same mutation. I think clinical polymorphism of this mutation not clear complectly at the present time.

    During exercise test  (tredmil test) PR interval shortening in one brother and was normal in other.

    Thank you another time.  

  • Ramarao Ganga added an answer:
    2
    How to go about if a pt c/o regurgitation of liquid food through the nose and mouth after heller cardiomyotomy?

    58 year man with Achalasia cardia who underwent Trans thoracic Heller"s cardio myotomy in 1962, started c/o of regurgitation of liquids from nose and mouth mostly at night for over one year.Details of the procedure are not available.Requested to have Upper GI scopy,Manometry and 24hr PH.Not a diabetic or Hypertensive.No respiratory symptoms.

    Ramarao Ganga

    Does he have Dysphagia? In any case I would start with UGI gastrografin or Barium. This would help to map out esophagus before EGD.  if this is recurrent achalasia, he may have megaesophagus or even epiphrenic diverticulae at risk of perforation.

    I would even entertain the possibility of Zenker's with that presentation. UGI study  should be able to show it too.

  • Ali A R Aldallal added an answer:
    4
    Any heart failure risk score?

    Dear all, 

    Are you aware of any established risk score that predicts particularly heart failure and not cardiovascular diseases as whole?

    Many thanks in advance!

    Ali A R Aldallal

    Heart Failure Risk Calculator
    Meta-Analysis Global Group in Chronic Heart Failure
    The Heart Failure Risk Calculator presents 1 and 3 year all-cause mortality estimates for people with heart failure, as developed and presented in Pocock et al. "Predicting survival in heart failure: a risk score based on 39372 patients from 30 studies" Eur Heart J 2012 doi:10.1093/eurheartj/ehs337.

    The intended audience for the Risk Calculator is health care professionals knowledgeable in cardiology and the management of people with heart failure.

    The model was constructed from research data collected from 1980-2006 and may not be indicative of current or future trends in heart failure management. The variability in risk between studies and cohorts is greater than that explained by known risk factors. True risk within any centre may be higher or lower than the stated estimates for 1 and 3 year mortality.

    This site and its contents are made available as a research courtesy, with no direct or indirect liability accepted by the Meta-Analysis Global Group in Chronic Heart Failure (MAGGIC), or the study sponsors: The University of Auckland, the New Zealand Heart Foundation, the University of Glasgow.

  • Victor Kovalets added an answer:
    12
    Is it possible to manually remove artifacts in Kubios HRV analysis ?

    Hi,

    I am interesting to find the answer to a question related to using Kubios (in particular it would be good to get advice from Mika Tawvainen who created the software but if anyone knows anything about this software I would very much appreciate your help). 

    I want to remove artifacts from some collected HRT and HRV data. My other colleagues have suggested that only automatic filters can be applied to parts of the data. However, the User's guide of Kubios seems to suggest you can remove artifacts manually. 

    If this is so am I correct in understanding that this can only be done using the ECG data but not the RR interval data displayed on the Kubios data browser?

    If this is the case as well, is it right to assume that in order to manually remove artifacts you would want to find data points on the RR interval data browser that seem like artifacts (e.g., they spike up very quickly and suddenly) and then find the corresponding part on the ECG data display and add a marker which would remove the data point so that it is not included as an R wave in the RR interval data browser. By doing this all the artifacts that seems like real R waves will be removed from the data resulting in "clean data" as free from artifacts as it is possible to get it.

    If this is all correct then I would assume my colleagues were not aware of a manual function to remove artifacts (i.e., they just used the automatic low, medium and high level artifact corrections) because their data did not have the ECG information which I underestand is required to manual remove artifacts. 

    It would be great if corrections can be made to my understanding where required.

    Many thanks,

    Victor

    Victor Kovalets

    Hi all,

    Apologies for the delayed reply. Thanks for all the help. I now have a much better understanding of what I want to do in Kubios. 

    In particular, I was not certain about whether to use automatic or some sort of manual editing so clarification on this has been important but so has the elaboration and further detail. 

    In my case I do have ECG data and so then, from my understanding, I will want to focus on manual artifact removal. To do this I would simply remove the R wave detection markers only (rather than using the other two option when right clicking on markers such as add and edit I think) and by doing this the RR interval data will change accordingly so that the artifacts will no longer be present. I should end up with better data which neither includes artifacts nor removes real data points as possible with automatic approach. 

    This makes better sense now. Thanks again for all the help all.

  • Julie Cox added an answer:
    1
    What are the reasons of in-stent restenosis after PTCA?

    Percutaneous transluminal coronary angioplasty (PTCA) is a minimally invasive procedure to open up blocked coronary arteries, allowing blood to circulate unobstructed to the heart muscle.

    Julie Cox

    Hi

    This is an interesting piece of work using an animal model which may help to answer your question. Best wishes

    + 2 more attachments

  • Tatiyana Vaikhanskaya added an answer:
    6
    This is patient's ECG after orthotopic heart transplantation. What is the rhythm?

    There is  ECG recorded in patient after orthotopic heart transplantation. What is rhythm?

    Tatiyana Vaikhanskaya

    Dear Colleagues. Thank you everybody. I agree with you and I think, too, that in the remaining part of the recipient`s atria there is atrial fibrillation/flutter while the donor atrium escaping ectopic inferior-atrial (perhaps nodal) rhythm.

    Dear Tony! Dear Vinícius Eduardo! You are absolutely correct that the donor heart is compromised as evidenced by the chronotropic incompetence of the sinus node and the expressed disturbances of repolarization (ST-T).

    Best regards

  • Ali A R Aldallal added an answer:
    16
    How to assess accuracy of prediction model?

    Hi,

    Can any one suggest a statistical test to determine the accuracy of a prediction model?

    The prediction model has been developed using multiple linear regression and the variables are continuous.

    I think R2 can be used. Any other test apart from R2?

    Thank you

    Saima

    Ali A R Aldallal

    3 Ways to Test the Accuracy of Your Predictive Models
     
    by Victoria Garment 
      
     In data mining, data scientists use algorithms to identify previously unrecognized patterns and trends hidden within vast amounts of structured and unstructured information. These patterns are used to create predictive models that try to forecast future behavior.

    These models have many practical business applications—they help banks decide which customers to approve for loans, and marketers use them to determine which leads to target with campaigns.

    But extracting real meaning from data can be challenging. Bad data, flawed processes and the misinterpretation of results can yield false positives and negatives, which can lead to inaccurate conclusions and ill-advised business decisions.

    There are many different tests to determine if the predictive models you create are accurate, meaningful representations that will prove valuable to your organization—but which are best? To find out, we spoke to three top data mining experts. Here, we reveal the tests they use to measure their own results, and what makes each test so effective.

    Compare Predictive Model Performance Against Random Results With Lift Charts and Decile Tables
    Karl Rexer is the founder of Rexer Analytics, a small consulting firm that provides predictive modeling and other analytic solutions to clients such as Deutsche Bank, CVS, Redbox and ADT Security Services. The measures his firm uses to create predictive models are often binary: people either convert on a website or don’t, bank customers close their accounts or leave them open, etc.

    Rexer’s firm creates models that help clients determine how likely people are to complete a binary behavior. These models are created with algorithms that typically use historical data pulled from the client’s data warehouse to characterize behaviors and identify patterns.

    To test the strength of these models, Rexer’s firm frequently uses lift charts and decile tables, which measure the performance of the model against random guessing, or what the results would be if you didn’t use any model. It’s a methodology commonly used to increase customer response rates by identifying the most promising targets.

    Let’s look at an example. One of Rexer’s clients wanted to create a more focused, cost-effective marketing campaign for the coming year, so he and his team built a predictive model for the client using data from the previous year’s campaign.

    In the previous year, the client had sent marketing material to 200,000 total leads, 1,579 of which became customers—a conversion rate of 0.8 percent. For the coming year, the client wanted to know in advance which of their new leads would be more likely to buy their product so they could focus their marketing efforts on this segment. Essentially, they wanted a smaller, cheaper campaign with a higher conversion rate.

    Rexer and his team first took the client’s lead data and randomly split it into two groups. Approximately 60 percent was used to build the model, while the other 40 percent was set aside to test it (known as the “hold-out” sample).

    Splitting the data “helps ensure that you’re not creating a ‘super’ model that only works on that one set of data and nothing else,” Rexer explains. “You’re essentially building something that works on two different sets of data.”

    Rexer and his team used a variety of data mining algorithms to comb through hundreds of data fields to find the best set of predictors that worked in the modeling sample. These predictors were used to identify a highly responsive subset of leads.

    This algorithm was then used to score each lead in the hold-out sample on a scale of 1 to 100 based upon the characteristics identified by the algorithm, such as how long the person had been a customer and various socio-demographic information. The closer to 100, the more likely the lead was to convert.

    The list of leads in the hold-out sample was then rank ordered by score and split into 10 sections, called deciles. The top 10 percent of scores was decile one, the next 10 percent was decile two, and so forth.

    For more plz read at following link.

    Regards

  • Mathias Aazami added an answer:
    14
    How long continue Aspirin prophylaxis after a surgical mitral repair with use of artificial cords and annuloplasty ring, with LVEF of 50%?

    Is there literature-guidelines in this field?

  • Fatima Leite added an answer:
    9
    What is your opinions about RA thrombosis managment in premature neonate?

    A 40 days premature neonate reffered other center due to large ra thrombosis.

    .he hasn't positive history of cvp catheter .

    in examination ,stable hymodynamic , normal saturation , gread 2/6 systolic murmur ,no sign of respiratory distress.

    in echo: a large echogenic ,pedinculated ,moveable thrombus protruding to tv ,area about 1.1 cm2 ,mild tr with p.pg= 27 mmhg ,otherwise is normal .

    what is your opinion about managment of this neonate?

    best regards 

    Fatima Leite

    As the patient is hemodynamic stable, I agree with the use of low molecular heparin as the best option for this baby. Removing the thrombus could cost a lot, as it is a premature, usually low weight and a premature heart that do not deal well with anemia and volume overload that would happen in procedures for trombectomy. A conservative approach with heparin is more reasonable to me, best regards

  • Maarten Heusinkveld asked a question:
    Open
    What is the most accepted/standardised method to identify the end-systolic datum point on a measured pressure-volume loop of the left ventricle?

    1) Left uppermost corner of the pressure-volume loop, 2) time point where "d pressure / d time" has its minimum, 3) etc.??. How do the computer algorithms in devices do this?

  • Narendra Kumar added an answer:
    6
    Can Valsalva manoeuvre used during psvt cause AF/VT/VF in patients with wpw?

    do you have any case reports or something about that?

    Narendra Kumar

    At the end of Valsalva manoeuvre, due to increased vagal tone, there is transient higher AV block which may terminate SVTs. But considering the patient with WPW, in case of higher AV block, there will be higher chances of conduction through accessory pathways. Thus, chances of VT, VF increases. Due to the similar mechanism, beta blockers and calcium channel clockers are not advised for wpw patients.  

  • Christoph Kampmann added an answer:
    3
    Ptmc in patients with mitral restenosis after previous mitral valve repair that included commisurotomy and mitral annuloplasty ?

    post  mitral valve  commisurotomy  and  ring annuloplasty 

    Christoph Kampmann

    unfortunately there is no good solution for your problem aside from surgical redo. catheter interventions will likely generate a severe regurgitation in a too small valve.

  • Olivier Zelphati added an answer:
    9
    Is anyone experienced at transfecting oligos at the early stages of hiPS cell differentiation towards cardiomyocytes?

    So far we tried liposome transfection kit with very low efficiency of success

    Olivier Zelphati

    Dear Daniele,

    I can recommend a transfection reagent called Lullaby Stem for your application

    You can find more information here:

    http://www.ozbiosciences.com/transfection-sirna/25-lullaby-stem-transfection-reagent-stem-cells-silencing.html

    If you need a sample, just let me know at tech@ozbiosciences.com

    Good Luck

    Olivier

  • Tatiyana Vaikhanskaya added an answer:
    9
    ECG Challenge from Circulation (2016;134:499) What is ECG-interpretation?

    James A. Reiffel presented an enigmatic ECG (Circulation. 2016;134:499. DOI: 10.1161/CIRCULATIONAHA.116.023662)

    The patient is a 52-year-old male corporate executive who comes to the office as a new patient, having just been relocated by his company. He gives a histy of smoking (1 pack per day for 25 years), hyperlipidemia, and hypertension, and he currently is taking a statin, an angiotensin receptor blocker, a β-blocker, and a daily aspirin. He denies any history of chest pain or dyspnea, other than 2 days of mild chest fullness with slight shortness of breath 2 months earlier during a vacation to Vail, Colorado, after a particularly stressful period at work. On return home, he saw his internist who told him, after obtaining a confirmatory echocardiogram, that he had experienced a myocardial infarction, but that his heart function was near normal. At that time, his medications were adjusted to his current regimen. He has no previous medical records with him, but denies any other recent or remote illnesses. An ECG is obtained and is shown (Figure below). What is your interpretation?

    Tatiyana Vaikhanskaya

    Dear colleagues, thank you all for your interest and attention.

    Best regards.

  • Immanuel Victor George added an answer:
    5
    Are there any simulators for validating reflectance pulse oximeters?

    Hi,

    I am looking for something which would help to validate reflectance pulse oximeter. Are there any simulators which technically be able to validating such type of sensors? So far, I have found only devices useful only in evaluating transmittance oximeters (what I have been informed by some manufacturers about).

    Sincerely,

    Mateusz Soliński

    Immanuel Victor George

    Many Thanks, Lets keep looking for..

  • Jun Chen added an answer:
    4
    What is the rationale about caprini risk score that the assessment of Venous thromboembolism risk ?
    as we konwn,the caprini score is the tool for assessment the VTE risk ,especially for the patients undgoing surgery in the post-opertive period. and the model is maked by Pro caprini.
    but ,i still donot understand the rantionale of the caprini score model, The first question , every risk factor has it's point,such as age 40-60 is 1point,age 60-74 represents 2 point, and so on, how to calculate the different point and what is the rationale, is there anyone can help me ,if you have some paper the intrdouce the method to creat the model? thanks a lot.
    Jun Chen

     Thanks for Dumitru Casian,and i have send a email about this query to seek advice to the Pro caprini and i hope to receive some feedback.

  • Tony Prothero added an answer:
    3
    Do you know changes of mitral regurgitation and aortic regurgitation after acute heart failure (from EF 55 % to 15 % ) due to various reasons ?

    Especially, I would like to know changes of valvular regurgitation with asystole state. I am trying to study degree (LVEDV or LVEDP) of LV distension  after acute HF.

    Tony Prothero

    Changes in LV dynamics and mitral regurgitation during , and post, acute heart failure are complex. They can be dependent on aetiology (ischaemic, MI, cardiomyopathy, infiltrative diseases etc.), and if there is any chronic component prior to the acute event. Generally speaking the LVESV and LVEDP will increase and the degree of mitral regurgitation will also be increased (especially if LVEDV and mitral annular size are increased) The consequent increase in LA pressure leads to increasing pulmonary venous pressures which is the driving force for pulmonary oedema.

  • Logan Michael Netzer added an answer:
    5
    Has anyone experience of acute cardiospasm as a psychological reaction?

    There seems to be a lot of websites referring to cardiospasm and achalasia of the oesophagus as an anatomical problem, but little about acute cardiospasm as an emotionally-induced reaction. I remember as a student seeing a man visiting his father in hospital (from an arab country) overcome with grief and doubled-over with intense pain beneath his lower sternum, and this responded to quiet reassurance from the senior physician who reassured me that this was cardiospasm which would clear up within an hour, which it did. Thanks for any insights from others who have seen this.

    Logan Michael Netzer

    Takotsubo or any type of cardiomyopathy is not what the question is even referring to. Cardiospasm is synonymous with achalasia which results from a painful esophagus that is dilated and typically leads to reflux and other nasty problems. The use of the prefix 'cardio' in cardiospasm refers to the cardiac sphincter of the stomach.

    Despite not addressing Richard Savage's question, you do bring up a highly interesting condition mainly because of the etiology of the condition's name. As you know the condition has been around for a very long time, however, takotsubo is Japanese which was the first country to document the condition and is a extremely collectivistic culture. While it does not seem to have a drastically higher prevalence in Japan than western countries it does seem right that the west would push strongly against a psychosomatic-esque condition until they had to accept it.

    This being said, I will not tell the story of a female very dear to me who was having severe panic attacks. These attacks were unquestionably psychological in nature and I am well aware of what would cause them. Sure enough, when the attacks would flare I would see the panic in her eyes and within seconds she would exhibit Levine's sign though she never had any actual cardiovascular issues. These attacks lasted for about 4 months with 1-3 occurring each day. And similar to what the individual  told Mr. Savage, I told her they would resolve within a 1/2 hour to hour,.. fortunately I was right.

    To sum up my main point, Yes! I have seen the phenomenon of which you speak of. In canines a condition resembling achalasia results from damage to the vagus nerve. I don't know if you care about that but though I would share.

    Wishing you all the best,

    Logan Netzer

    P.S. Just a few canine studies that I briefly mentioned.

    J Neurol Neurosurg Psychiatry. 1982 Jul;45(7):609-19. Abnormalities in the vagus nerve in canine acrylamide neuropathy.Satchell PM, McLeod JG, Harper B, Goodman AH.

    J Neurol Neurosurg Psychiatry. 1981 Oct;44(10):906-13. Megaoesophagus due to acrylamide neuropathy. Satchell PM, McLeod JG.

  • Tiit Kööbi added an answer:
    6
    Pulse wave velocity quantification using echocardiography?

    Dear experts,

    Do you measure pulse wave velocity using echocardiography (PW-Doppler)? What is your experience or opinion about this method?

    Many thanks in advance,

    Vladislavs

    Tiit Kööbi

    Yes we do but we prefer to use the impedance technique for PWV measurement. It is easy to use, fully automatic and operator-independent.

    http://www.ncbi.nlm.nih.gov/pubmed/12558611

    https://tampub.uta.fi/bitstream/handle/10024/99556/978-952-03-0124-8.pdf?sequence=1

  • Thomas Brand added an answer:
    8
    Which part of the heart is central? Is there explanation as to why the sinoatrial node (SA node) is positioned in the right atrium?

    why not at the center of the heart or in any of the other 3 chambers?

    Thomas Brand

    The question why something is like it is, is a teleological question. Since organs like organisms  have an evolutionary and developmental origin, one has to look into both to get an idea why. The sinuatrial and atrioventricular nodes are the remnants of the linear heart tube, which is the first functional state of this organ. Looping and ballooning positions this myocardium to its locations found in the mature organ. The heart has the ability to generate nodes on both sites of the venous inflow tract, however development of a second sinuatrial node is blocked on the left side by Pitx2. I would consider the atrioventricular node to be central between the atria and ventricles. It is also partly positioned to the right in the atrial floor due to the looping process and remodeling. There are certainly also biophysical and mechanical aspects to the positioning of the conduction tissue. The structure of the mammalian and also the human heart can be followed back to the primitive hearts found in lower chordate hearts, like the heart of Ciona,  however we lack good insight into the evolutionary origins since hearts so not survive fossil formation. In the Heart of tunicates both inflow and outflow trägt are equvalent and Act als pacemaker

  • James Pate added an answer:
    3
    The heart valves are irrigated by blood vessels in surface the valves or by diffusion or both?

    what is the evidence of this in humans and its applicability in endocarditis?

    James Pate

    The two papers above are good.  Harper's paper is a classic.  Having studied dozens of valves, microscopically, I never saw blood vessels within the substance of the leaflet of NORMAL valves.  It appears that inflammed valves develop neovascularity just as in other "granulation" tissues.

  • Antonio Vittorino Gaddi added an answer:
    8
    What is the hottest research area in cardiovascular field?

    Hello, friends.

    I am a new researcher in cardiovascular field and looking for a promising research point. Do you have any advice? 

    And I am looking forward to sharing my ideas with you. If we can cooperate, it couldn't be better! 

    Thanks in advance for your help!

    Antonio Vittorino Gaddi

    I believe that we know (maybe) 5% of what it would be useful to know about humans and about  cardiovascular system. Then there are plenty of useful research, "hot" and interesting. There is still much to discover. The important thing is that searches are well designed and well conducted and that researchers are free

  • Narendra Kumar added an answer:
    22
    What do you think about dabigatran instead of warfarin in atrial fibrilation?

    Since the point that the first one is more unafforfable in the real world.

    Narendra Kumar

    I would highly recommend to read my 2 co-authored articles mentioned below. If u need the full manuscript, feel free to write to me.

    Phan K, Wang N, Pison L, Kumar N, Hitos K, Thomas SP: Rivaroxaban versus warfarin or dabigatran in patients undergoing catheter ablation for atrial fibrillation: a meta-analysis. International journal of cardiology Int J Cardiol. 2015 Apr 15;185:209-13.DOI: 10.1016/j.ijcard.2015.03.102

    Phan K, Wang N, Pison L, Kumar N, Hitos K, Thomas SP: Meta-analysis of dabigatran vs warfarin in patients undergoing catheter ablation for atrial fibrillation. International journal of cardiology 04/2015; DOI:10.1016/j.ijcard.2015.04.072

  • Heiko E. von der Leyen added an answer:
    5
    Does anyone know of an efficient alternative to the rat carotid balloon injury to create consistent intimal hyperplasia?

    Dear all,

    I am looking for an efficient way to create intimal hyperplasia in rat arteries as an alternative to the carotid artery ballon injury model. Efficient and reviewed methods and ideas are highly appreciated! 

    Thank you in advance!

    Heiko E. von der Leyen

    That's so so called cuff method - it workes, there are several paper out describing this method, e.g. the following:

    Interposition Vein Cuff and Intimal Hyperplasia: An Experimental Study
    2004     L. Fleurisse

  • Nayab Batool Rizvi added an answer:
    5
    What do you think about the IgE as a cardiovascular risk factor and cardiovascular disease?

    Nowadays, it is a very important link that should not be dismissed. Please reply.

    Nayab Batool Rizvi

    If i m not wrong IgE is mainly meant for allergic reactions triggered by ur immune system. but yes link of it to CVD can be considered

  • Filip Konecny added an answer:
    2
    Sheep reversal using protamine sulfate (P.S)?

    Sheep reversal using protamine sulfate (P.S).

    In 1990 literature describes ability to slowly inject (over 30 min) P.S. to reverse heparin (Anesthesiology. 1990 Sep;73(3):415-24). In May 1988, (Circ Res. 1988 May;62(5):905-15), authors discussing possible reasons why sheep reacts: “Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Evidence for the role of reactive oxygen metabolites following nonimmunological complement activation”.

    Many surgical groups have then switched to LMWH when performing cardiac procedures like in the submission in 2015 by Dr. Schmitt from Pediatric Cardiology from Berlin Heart: entitled” Administration of Dalteparin in Sheep for Cardiac Interventions”.

    A)      Is there any published literature/or empirically tested (unpublished) about Dalteparin reversal using Protamine Sulfate, in terms of dosages of P.S, and its timing and proper monitoring including P.S. titration that can be easily performed in the animal OR?

    B)      Is there any literature about P.S. reversal of any other LMWH used in sheep cardiac procedures?

    Filip Konecny
    thank you, some of your attached articles have interesting scientific information I can use to look for a dose. Thank you again,
    Filip
  • Immanuel Victor George added an answer:
    3
    Spontaneous reversion of vasovagal reflex induced cardiac arrest?

    Can a cardiac arrest caused by vasovagal reflex spontaneously revert to normal rhythm some minutes later?

    Anyone please suggest the possibilities and mechanism.

    Regards

    Immanuel Victor George

    Reversal from Cardiac Arrest:

    If its peri-arrest - Spontaneous return of circulation depends on upon various factors (physical conditions)

    If it is confirmed arrest:- 

    Shockable Rhythm :- High chance of spontaneous return within in 1 minute

    Non-Shockable Rhythm - Very poor chance for spontaneous return

    Witnessed arrest have higher rate of spontaneous return compare to  un-witnessed arrest.

    This is  highly evident in highly specialized care environment  such as Cardiac theatre, Cardiac ICU, Interventional and non interventional CV procedure room, A&E

    Regards

    Immanuel Victor George

  • Aaysha Cader added an answer:
    7
    In the GRACE RIsk Score, what constitutes the term " ST segment deviation"?

    In order to constitute the criteria of "ST segment deviation" during calculation of the GRACE Risk Score, , Is it EITHER the presence of ST segment elevation or ST segment depression that is necessaryy? SO if either of the two is present,does it fulfil a criteria? What about LBBB?

    Aaysha Cader

    Thanks for the input. this was very useful :)

  • Zeng Huayuan added an answer:
    4
    Can we use GsMTx4, a selective SACs inhibitor, in vivo?

    GsMTx4 is a selective SACs inhibitor which extracted from tarantula venom. less was reported about it's use in  in vivo tests. I found only two article mentioned about the in vivo test ,one of which used a recombined GsMTx4.

    Zeng Huayuan

    Thank you.

  • Amr Muhammad Abdo Salem added an answer:
    7
    What is the most fitting animal model for cardiology studies?

    What is the most fitting animal model for cardiology studies?

    Amr Muhammad Abdo Salem

    Guinea pigs

  • Andrei G Dan added an answer:
    3
    Risk adjusted in-hospital mortality for the actue myocardial infarction. Role of hypertension and other protective comorbidities. Explanations?

    Risk models for the inhospital-mortality of the acute myocardial infarction show in many investigations also "protective" variables, like hypertension or dyslipidaemia. These results are not only presented in the literature, but also used (in my opinion) for the public hospital benchmarking. For example: 2015 Condition-Specific Measures updates and Specifications report hospital level 30-Day Risk-Standardized Mortality Measures (version 9.0).

    Some different attempts for explanation (Hypertension):

    "Observational and modeling studies of the ischemic heart disease mortality decline in the United States found that the decline was due to a combination of improved risk factor patterns (primary prevention due presumably in part to dietary changes but also to dyslipidemia and hypertension treatment) and improved acute myocardial infarction treatments." Moran A, Odden MC. Trends in Myocardial Infarction Mortality in Spain and the United States: A Downhill or Uphill Race in the Twenty-first Century? Revista Española de Cardiología (English Edition). 2012; 65(12): 1069–71.

    "With increasing admission blood pressure, long-term mortality decreases, with a systolic blood pressure above 160 mmHg being associated with best outcome. Blood pressure modifying medication at admission had no influence on this effect. This suggests that low, and even low-normal, admission blood pressure should serve as a warning sign in patients with AMI. Admission blood pressure should therefore be interpreted in opposite to the regular, preventive, point of view."Roth D, van Tulder R, Heidinger B et al. Admission blood pressure and 1-year mortality in acute myocardial infarction. Int J Clin Pract. 2015; 69(8): 812–9.
    One explanation from the disussion is, that the heart is still able to react in this acute phase.

    "...hypertension may be a marker for the absence of low blood pressure, which may be caused by cardiac pump failure and therefore indicate greater cardiac disease severity....paradoxical relationships may reflect coding bias in administrative data, in that patients with serious disease or complications are less likely to have certain common conditions coded, even when present." Vaughan-Sarrazin MS, Lu X, Cram P. The impact of paradoxical comorbidities on risk-adjusted mortality of Medicare beneficiaries with cardiovascular disease. Medicare Medicaid Res Rev. 2011; 1(3): 17.

    And finally the GRACE score for in-hospital mortality:
    The higher the SBP, the less risk points are given.

    What do you think? Are there further statements or experiences?

  • Sujay Shad added an answer:
    1
    Any suggestions on transcardial perfusion with adenosine?

    Hello,

    Can anyone recommend a protocol for rat transcardial perfusion with adenosine-induced vasodilation. I am trying to repeat an experiment of another researcher but they never left any concentrations and/or route of administration nor any reference! I am interested in what dose of adenosine to use, at what point and how to administer it?

    Thank you al for contribution to solving my problem

    Best wishes

    Sujay Shad

    One surgeon used to use 6 mg intraaortic prior to release of cross clamp.  

  • Nataliya Borisovna Pankova added an answer:
    17
    Heart rate variability and age in non-linear relationship?

    I have a cohort study of an elderly population (45-85 years old) and I found in opposite to many others that sdnn is increasing with age, the cutpoint could be about 70 years. It seems to could be explained with an additional quadratic term in regression, but I wonder if any other colleagues have similar results?

    Nataliya Borisovna Pankova

    I did not check my data in the statistical models, because as it is only a description, without physiological foundations. I like the suggestion of Dr  Sven Rupprecht: those who active lives in 80 a priori more healthy, than those who died in 60. Especially in our sample. The vast majority of our cohort are people who have reached retirement age (in Russia 55 years for women and 60 years for men) and continue to work as a teacher at the school. I have some reasons to believe that those who stopped working at thease ages, have several other parameters of HRV.

    Nevertheless, it is awesome that our data do not contradict each other. There is a wide field for discussion and planning of new studies.

  • Rayan Ballal added an answer:
    2
    Hello every one. does anyone have a questionnaire on medication adherence for cardiology medicines ? or any one have done a project about that?

    medication adherence for cardiology medicines

    Rayan Ballal

    thank you for your reply Tanja 

    yes it is the one that i intend to use but i would like to know is there is another one 

    thank you 

  • Joe Graymer added an answer:
    17
    Chronic pericardial effusion, what is the etiology? What is the next step?

    A 84 year old woman with hypertension, 2 type diabetes mellitus and chronic renal failure (GFR 30-50 ml).
    2005 NSTEMI: LAD and LCX PCI
    2006 angina pectoris: distal RCA PCI. LAD and LCX stents no changes
    2014 UA: RCA ISR. 1 BMS implantation. Other stents without ISR 
    Echocardiographia all the time showed good systolic ejection fraction with good wall motions. 

    In 2014 starts: in ECHO showed a non siginificant pericardial effusion. After coronarographia seen hematuria and anemia. 
    An urological examination was negative for tumor, but an pelvis CT was done, whith some negative result.

    2014.07 gastroscopia: duodenitis erosiva and chronic erosive gastritis was.
                  colonoscopy: negative
    2015.08.03-04 was admited with melena.  Gastroscopy and colonoscopy was not showed a point of bleeding. 3 U of blood was transfused.
    An echo showed a significant pericardial effusion and a pericardiocentesis was performed. 1200 cc. straw-yellow liquid evacuated. And other day 100 cc.

    2015.08.05-12 admited to hospital with anemia for blood transfusion. Colonoscopy was done again.  The source of bleeding was not found. A polyp of the  Bauchin valve was cut of.

    The histology result of the colonoscopy sample not confirmed malignancy.

    2016.01.05 Admited agin with huge pericardial effusion and symptoms of HF. 1500 cc straw-yellow liquid evacuated. A pleural effusion was this time and a diagnostic thoracocentesis was done.

    The results from the pleural fluid showed a sigillocellulare cc. cells
    The CA 125 was elevetad.  (95 the normla range upper limit is 35 at our lab)
    Pericardial fluid: eosinophil cells, mesothel and lymphoid cells was seen.


    An cardiac MR was done with negative result for a  autoimmune disease or primer cardiac malignancy.

    An chest CT was done: negative for cc.
    An abdominal and pelvis MR was done: at the point of obturator in both side an 6 mm diameter  lymphaticus nodus was detected. In the corpus of uterus an 8 mm myoma detected (T2)

    Tuberculosis negative.
    The hemoculture results is negative

    2016.04.20 was admited with huge pericardial effusion. 1200 cc bloody liquid was evacuated. 
    And now 2016.05.31. Again was admited with effort dyspnoe and not a very huge pericardial effusion.
    The pericardial effusion sizes was 30-35 mm mostly left side and 25 mm from apex and right side.

    The gastroentereologist, onkologist, gynecologist and urologyst do not know the reason of chronic pericardial effusion. Please help, what is the diagnostic option which can use to find the cause of pericardial effusion.

    Thank you that you read and help.

    Joe Graymer

    In Chronic Kidney Disease, Effusions are not exceptional, some drugs, as Minoxidil, were connected to Pericardial effusions, for malignant effusions, local 5-FU or Thiotepa were used, also Radioactive Coloidal Gold as Brachytherapy. FU is connected to worsening Ischemic Heart Disease. The condition whose exact nature is not fully known is hard to treat and to issue a prognosis. Best for you and your patient. Regards, + Salut 

  • Norbi Gabor asked a question:
    Open
    It is in the new HF 2016 esc guideline, how to understand it?

    The clinical relevance of myocardial ischaemia for the provocation of ventricular arrhythmias is uncertain, although anecdotal cases of ischaemia-induced arrhythmias exist.

    That mean’s that ischaemia cannot provocat VT or only in rarley cases? 

    Thank you

  • Muralidharan R.s. added an answer:
    9
    Cardiac arrest without heart disease and unresponsive to defibrillation.
    A few years ago, Wikipedia's "Cardiac arrest" article had a short paragraph which stated that about 1 in a 1000 people (if I remember correctly) die from a spontaneous cardiac arrest which does not respond to defibrillation and cannot be linked to heart disease (i.e. post-mortem examinations show no signs of heart disease). If you are knowledgeable in the matter, please comment.
    Muralidharan R.s.

    Sudden  cardiac  Death (  SCD ) is  a  well accepted  entity  that can  occur  in  structurally  normal  heart.  Classical  eg. Brugada  syndrome, Congenital  Long Q-T Syndromes where  the  patient  die  of  Ventricular  Fibrillation  not  responding  to DC  shock. Postmortum Heart :  structurally  normal  but  having  genetic  based  functional  abnormality  not  found  in autopsy.

  • Muralidharan R.s. added an answer:
    5
    What is the clinical feature of acute rheumatic fever?
    What is the clinical feature of acute rheumatic fever?
    Muralidharan R.s.

    The clinical  picture  of  Rheumatic  Fever  is  divided  into 

    1)  Classical  Major  and  Minor  Criteria

    2) Atypical  Manifestation  of  Rheumatic  Fever

    Major  Criteria  are i) Migrating non deforming  Major  joints  arthritis ii) Pan Carditis  iii) Sydenham's  Chorea iv) Erythema  Marginatum v) Sub  cutaneous nodules.

    Minor  Criteria :  Fever > 38.5 degree C,  olyarthalgia, raised  ESR > 60  mm first  hour, Prolonged  PR  interval > 200 msec, Previous  history  of  Rheumatic  fever, Evidence  of  previous  streptococcal  throat  infection, a  positive  throat  culture for  group A  beta  haemolytic  strptocooci,  A positive rapid group A streptococcal carbohydrate antigen test ,  Raised  ASO  titre > 12, increased  CRP > 3.0 mg/dl.

    Atpical  manifestation  incldes  abdominal  pain,  epistaxis,  Jaccoud's athritis.

    Reference :  Dr.  Mrs. Padmavathy in  Text  book  of  Paediatrics, New Delhi,  India

    American  Journal  of  Cardiology,  May 08, 2015 | David S. Bach, MD, FACC,  

  • Ian S. deSouza added an answer:
    4
    What is the first drug of choice of AVNRT ?

    Many  prefer  Inj. Adenosine -  Needs Central venous / intra atrial administration owing  to  its very  short  half  life. Inj. Amiodarone has  an  unpredictable  half  life. What  next ?

    Ian S. deSouza

    Adenosine and calcium-channel antagonists have both demonstrated efficacy. See attached.

    + 1 more attachment

  • Tatiyana Vaikhanskaya added an answer:
    1
    Honesty in medical world?

    Where you find that big names in Cardiology are simple men....http://cardiobrief.org/2016/06/07/prominent-cardiologist-and-esc-presidential-candidate-found-guilty-of-fraud/

    Are we naive enough to still believe in absence of conflict of interest, and pure honesty in medical science? Does it really exist? Or should we shift completely the paradigm and assume everybody is lying/hiding something and accept it?

    For any new scientific finding, the question is not "how close is it from truth?" but rather, "how far is it from truth?".

    Tatiyana Vaikhanskaya

    I think it's a sad manifestation of the general trend in all areas, unfortunately :-(

  • Alia Al Khozondar asked a question:
    Open
    What is the blood pressure threshold for Isosorbide dinitrate administration?

    Is there a level that you can't administer Isosorbide dinitrate when a patients blood pressure is below it? 

  • Maia Chigogidze added an answer:
    7
    Is there any study about gender differences in Coronary collateral circulation?

    CAD;Coronary Collateral circulation

    Maia Chigogidze

    Thank you for information,I'll see .

  • Mohamed S Kabbani added an answer:
    3
    Is there any evidence for corticosteroids in patients with acute myocarditis?
    In some centres patients with heart failure due to (biopsy-proven) myocarditis are being treated with corticosteroids. Does anybody know if there is clincal evidence or prospective studies?
    Mohamed S Kabbani

    We did not notice in our practice an improvement in outcome of children with myocarditis receiving corticosteroid. 

  • Robert Michael Davidson added an answer:
    6
    What is the minimum effective anti-inflammatory dose of commonly used statins in CAD?
    At what dose do we see the antiinflammatory effects of statins in CAD? Importantly, how do we monitor this activity? Is the fasting lipid panel an adequate measure?
    Robert Michael Davidson

    Would it perhaps be safer to manage inflammation with ascorbic acid and electrolyzed reduced water than with a statin?

  • Laurie Coppola added an answer:
    5
    How rapidly can the ductus arteriosus close?

    I know typically the ductus arteriosus closes during the first day of life.  Is there any information as to how quickly is closes once it starts to close?

    Laurie Coppola

    The ductus arteriosus can close prenatally in some cases.  

    I'm not sure if it's been studied to ascertain the quickest time from the start of closure until it is no longer physiologically patent, but prenatal closure can lead to RV hypertrophy.  When prostaglandins are used to maintain a PDA in suspected ductal-dependant pulmonary flow, physiological closure can be auscultated sometimes hours after PGE1 is stopped, but I'm guessing that's also dependent on the age of the neonate and the  PaO2 at initiation.

  • Lutz Kraushaar added an answer:
    5
    Is anybody interested in a collaboration to test the first medical avatar of the human arterial tree?

    Dear All

    With funding from the German government we have recently finalized the development and medical registration (EU) of the vasometrix™ System, whose integral part is arteroid™, the first medical avatar of the human arterial tree. Powered by artificial intelligence and evolutionary algorithms, this model of the human arterial tree replicates a proband’s non-invasively acquired ultra-high-resolution pulse pressure curves. With correlations of up to >99% the valiant parameters of arterial function are being derived with high accuracy: such as central pressures, compliance, TPR, augmentation pressure and index, vascular age. The very recently completed system has been validated against invasive blood pressure measurement and presented for the first time at the annual congress of the German Cardiology Association in early April this year.

    I am now looking for collaborators who see the benefits of applying vasometrix in research projects or population studies, in which various parameters of arterial function are desired efficacy endpoints.

    For a first impression of the system you may visit www.vasometrix.com (currently in German only) or watch a 2-minutes introductory video here: vimeo.com/162808038

    In case of interest, kindly contact me directly at lutz.kraushaar@adiphea.com

    Thanks and best wishes

    Lutz

    + 1 more attachment

    Lutz Kraushaar

    @ Alexander Valdés Martín & Miikue-Yobe Togenu

    Thank you very much for your kind interest. 

    Due to medical registration aspects we have to limit the geographical area of application of vasometrix to EU.

    Best wishes

    Lutz 

  • Aas Majumder added an answer:
    5
    When dealing with hypertensive patients with black color, will the management differ if the patient is from AfricoAmerican origin or not?

    Does the definition of "black patients" include non Africo-Americans?

    Aas Majumder

    Whatever the genetic basis in different racial groups, we follow the International Society oh Hypertension guideline Jornal of Clinical Hypertension Vol. 16; No.1; January,2014 )  to give ACEI?ARBs as first line regimen in non-black people and calcium channel bolckers & diuretics in black poeople ahich are derieved from different prospective trials.

  • Sven Persoon added an answer:
    5
    Incomplete Homogenization of fibrotic Heart tissue with Trizol and Problems with RNA Extraction. Can anybody help me?

    Hello,

    i have some Problems with Homogenization of fibrotic heart tissue for RNA extraction. I use a fastprep 24 Homogenizer.

    I put about 40 mg of tissue in a precellys hard tissue lysing kit with 1 ml of trizol. Because the homogenisation is so difficult, i even put another 1/4 ceramic sphere into the kit

    No matter how long i try to homogenate, there always stay some chunks in the vessel 

    I followed the trizol protocol and even added a centrifugation step before adding Chloroform to get rid of unsolveable Proteins and DNA, but after centrifugation there always stayed a supernatant of very small chunks on the top of the aqueous phase which is not fed.

    What can i do for a complete homogenisation, what might be the reason for the supernatant of chunks?

    Sven Persoon

    I figured out a way to get rid o the unsolveable Proteins: I used the Qiagen Shredder Columns directly after centrifugation, soi had a clear suparnatant after the chloroform addition

  • Oleg Lookin added an answer:
    8
    What would be a critical in isolation of guinea pig cardiomyocytes?

    Hi everyone!

    I would appreciate for helping me with a protocol of isolation of guinea pig cardiomyocytes.

    The animals aged 2-3 months. They euthanized appropriately, a heart is quickly (30 seconds) removed from the chest and transferred into cold saline (~10 C) where I gently push the heart to remove blood remnants from the chambers, then remove unused parts of vessels etc. This step may take up to 1 min. Then I cannulate the heart aortically to the Langendorff system. The system is filled with saline of the following composition (mM): 140 NaCl, 5.5. KCl, 1.2 MgSO4, 1.8 CaCl2 dihydrate, 10 HEPES, 11.1 glucose (pH adjusted to 7.4 with NaHCO3 and KH2PO4 under bubbling with 95% O2 + 5% CO2). Just before the cannulation, I start the perfusion at the rate of ~1 drop/second (~8 ml per minute). When cannulation is done, I ligate the pulmonary veins and make a small hole in the pulmonary trunk to reduce loading of the right ventricle. Then the heart is allowed to equilibrate at the flowing rate of ~8 ml/min, at 37 C, and with bubbling by 95% O2 + 5% CO2. Typically, the heart looks to be perfused adequately, contracts regularly at the rate of ~150 beats/min. As long as I perfuse the heart with Ca-containing saline, it beats strongly and rhythmically. After ~10 min steady-state contractions, I replace the solution to nominally Ca2+-free solution (25 uM CaCl2 dihydrate, other components are the same) and perfuse the heart 10 minutes more (until the cessation of beating) or longer. In some cases, I replaced the perfusion back to normal Ca and the beatings restored completely both with strength and rate. As the beatings stopped, I replace the perfusion to nominally Ca2+-free saline (25 uM CaCl2 dihydrate) + collagenase type II (Worthington). I tried different concentrations of collagenase, from 0.1 mg/ml to 1 mg/ml. This perfusion is not looped and goes under extensive bubbling by 95% O2 + 5% CO2. Depending on the concentration of collagenase, I need 5 to 10 minutes of such perfusion to get marbled heart. Immediately after this is occurred, I remove ventricles and put them into a flask with nominally Ca2+-free saline (25 uM CaCl2 dihydrate) without collagenase at room temperature (without perfusion) and cut the ventricles to small parts. Then I start to dispense the parts by gentle sucking (I use 1 mL pipette holder and use standart pipette with open side about 5 mm and also with smooth edges). Shortly after I can see suspension but it does not contain living cells or even cells with typical morphology (all cells are died). If I continue to dispense the tissue, I could get very small amount of cells (<5%) with normal shape but bad striation and bad membrane.

    The same step-by-step protocol (but with slightly modified saline) I use to isolate rat cardiomyocytes. Normally, the isolations are successful, and I can see living cells at the very beginning of dispensing step.

    I would be so thankful for advising me about the isolation of guinea pig cardiomyocytes or pointing me out to my possible errors.

    (Additional: I definitely use heparin both before euthanasia and during initial perfusion of the heart)

    Oleg Lookin

    Jose, thanks for your feedback! I understand now that the size of a heart (possibly not size of an animal or age) is critical for the perfusion time. Do you weigh a heart before cannulation? I would use some free available "weight-time" tables (but for rats) to choose appropriate time. Also, I do tried trypsin in a few cases but without significant changes in the outcome of the cells. Again, I can see that my total time in collagenase is too short, so I think this is the main step I will check in future.

About Cardiology

Cardiology - serves as a discussion platform for clinicians, clinical researchers or basic scientists interested in cardiovascular diseases. For those of you also interested in cardiac electrophysiology please check out the two complementing groups “Cardiac Electrophysiology” and “Catheter Ablation of Arrhythmias”.

Topic followers (124,606) See all